Published in J Biol Chem on September 08, 1995
The histone acetylase PCAF is a nuclear receptor coactivator. Genes Dev (1998) 2.58
Yeast RSP5 and its human homolog hRPF1 potentiate hormone-dependent activation of transcription by human progesterone and glucocorticoid receptors. Mol Cell Biol (1996) 1.70
Identification of a novel RING finger protein as a coregulator in steroid receptor-mediated gene transcription. Mol Cell Biol (1998) 1.60
Molecular cloning and analysis of two subunits of the human TFIID complex: hTAFII130 and hTAFII100. Proc Natl Acad Sci U S A (1996) 1.59
Chromatin-dependent cooperativity between constitutive and inducible activation domains in CREB. Mol Cell Biol (2001) 1.46
Activation of androgen receptor function by a novel nuclear protein kinase. Mol Biol Cell (1998) 1.13
Role of hydrophobic amino acid clusters in the transactivation activity of the human glucocorticoid receptor. Mol Cell Biol (1997) 0.97
Oestrogen receptor facilitates the formation of preinitiation complex assembly: involvement of the general transcription factor TFIIB. Biochem J (1998) 0.91
16 alpha-substituted analogs of the antiprogestin RU486 induce a unique conformation in the human progesterone receptor resulting in mixed agonist activity. Proc Natl Acad Sci U S A (1996) 0.86
E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol (1991) 8.60
An estrogen-responsive element derived from the 5' flanking region of the Xenopus vitellogenin A2 gene functions in transfected human cells. Cell (1986) 5.22
Detection of human immunodeficiency virus type 1 provirus in mononuclear cells by in situ polymerase chain reaction. N Engl J Med (1992) 3.64
Double-blind, placebo-controlled food challenge (DBPCFC) as an office procedure: a manual. J Allergy Clin Immunol (1988) 3.57
Interaction between Gab1 and the c-Met receptor tyrosine kinase is responsible for epithelial morphogenesis. Nature (1996) 3.00
Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor. EMBO J (1992) 2.65
The Met receptor tyrosine kinase transduces motility, proliferation, and morphogenic signals of scatter factor/hepatocyte growth factor in epithelial cells. J Cell Biol (1993) 2.53
Coupling of Gab1 to c-Met, Grb2, and Shp2 mediates biological responses. J Cell Biol (2000) 2.48
Hepatocyte growth factor/scatter factor induces a variety of tissue-specific morphogenic programs in epithelial cells. J Cell Biol (1995) 1.91
Sequential requirement of hepatocyte growth factor and neuregulin in the morphogenesis and differentiation of the mammary gland. J Cell Biol (1995) 1.91
The E-cadherin promoter: functional analysis of a G.C-rich region and an epithelial cell-specific palindromic regulatory element. Proc Natl Acad Sci U S A (1991) 1.74
A functional domain in the heavy chain of scatter factor/hepatocyte growth factor binds the c-Met receptor and induces cell dissociation but not mitogenesis. Proc Natl Acad Sci U S A (1992) 1.70
Smoking and cancer-related gene expression in bronchial epithelium and non-small-cell lung cancers. J Pathol (2006) 1.66
Reconstitution of mammary gland development in vitro: requirement of c-met and c-erbB2 signaling for branching and alveolar morphogenesis. J Cell Biol (1998) 1.56
Novel p62dok family members, dok-4 and dok-5, are substrates of the c-Ret receptor tyrosine kinase and mediate neuronal differentiation. J Cell Biol (2001) 1.52
Percentage of smudge cells determined on routine blood smears is a novel prognostic factor in chronic lymphocytic leukemia. Leuk Res (2010) 1.51
Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia. Leukemia (2005) 1.47
Tuning spin-orbit coupling and superconductivity at the SrTiO{3}/LaAlO{3} interface: a magnetotransport study. Phys Rev Lett (2010) 1.36
Signaling of hepatocyte growth factor/scatter factor (HGF) to the small GTPase Rap1 via the large docking protein Gab1 and the adapter protein CRKL. J Biol Chem (2000) 1.22
Gene expression signatures separate B-cell chronic lymphocytic leukaemia prognostic subgroups defined by ZAP-70 and CD38 expression status. Leukemia (2006) 1.22
Bone marrow fibroblasts induce expression of PI3K/NF-kappaB pathway genes and a pro-angiogenic phenotype in CLL cells. Leuk Res (2008) 1.19
Sex differences in baseline neuropsychological function and concussion symptoms of collegiate athletes. Br J Sports Med (2006) 1.16
Mutation of juxtamembrane tyrosine residue 1001 suppresses loss-of-function mutations of the met receptor in epithelial cells. Proc Natl Acad Sci U S A (1995) 1.13
Introduction of estrogen-responsiveness into mammalian cell lines. Nucleic Acids Res (1986) 1.11
Molecular characteristics of HGF-SF and its role in cell motility and invasion. EXS (1993) 1.10
Engineered mutants of HGF/SF with reduced binding to heparan sulphate proteoglycans, decreased clearance and enhanced activity in vivo. Curr Biol (1998) 1.10
Mechanism of estrogen receptor-dependent transcription in a cell-free system. Mol Cell Biol (1990) 1.07
ZAP-70 expression is a prognostic factor in chronic lymphocytic leukemia. Leukemia (2003) 1.06
Serum and urine markers of bone metabolism during the year after hip fracture. J Am Geriatr Soc (2001) 1.05
Human insulin receptor substrate-2 (IRS-2) is a primary progesterone response gene. Mol Endocrinol (1999) 1.04
A cell-specific activator in the Xenopus A2 vitellogenin gene: promoter elements functioning with rat liver nuclear extracts. EMBO J (1988) 1.03
The influence of phenobarbital on the turnover of hepatic microsomal cytochrome b5 and cytochrome P-450 hemes in the rat. Biochim Biophys Acta (1970) 1.03
Interaction between the phosphotyrosine binding domain of Shc and the insulin receptor is required for Shc phosphorylation by insulin in vivo. J Biol Chem (1996) 1.02
Elements and factors involved in tissue-specific and embryonic expression of the liver transcription factor LFB1 in Xenopus laevis. Mol Cell Biol (1993) 1.02
Clinical and mutation data in 12 patients with the clinical diagnosis of Nager syndrome. Hum Genet (2013) 1.00
Developmental regulation and tissue distribution of the liver transcription factor LFB1 (HNF1) in Xenopus laevis. Mol Cell Biol (1993) 0.98
Human insulin receptor substrate-2: gene organization and promoter characterization. Diabetes (1999) 0.96
Isolation of DICE1: a gene frequently affected by LOH and downregulated in lung carcinomas. Oncogene (1999) 0.96
Evaluation of caffeine as a test drug for CYP1A2, NAT2 and CYP2E1 phenotyping in man by in vivo versus in vitro correlations. Pharmacogenetics (1996) 0.96
[The arteria radialis superficialis. An unusual variation of the arteria radialis of man and its phylogenetic significance]. Acta Anat (Basel) (1987) 0.96
The role of E-cadherin and scatter factor in tumor invasion and cell motility. EXS (1991) 0.95
Role of HGF/SF and c-Met in morphogenesis and metastasis of epithelial cells. Ciba Found Symp (1997) 0.95
The effect of starch malabsorption on fecal short-chain fatty acid excretion in man. Scand J Gastroenterol (1988) 0.95
Endovascular treatment of intracerebral arteriovenous angiomas. Technique, indications and results. J Neuroradiol (1984) 0.94
Prevention of recurrent acute otitis media: chemoprophylaxis versus tympanostomy tubes. Laryngoscope (1986) 0.94
Properties and functions of scatter factor/hepatocyte growth factor and its receptor c-Met. Am J Respir Cell Mol Biol (1993) 0.94
[Schwannoid tumor of the lateral ventricle]. Neurochirurgie (1966) 0.94
Estrogen and progesterone receptor-binding sites on the chicken vitellogenin II gene: synergism of steroid hormone action. Mol Cell Biol (1988) 0.94
Estrogen-inducible derivatives of hepatocyte nuclear factor-4, hepatocyte nuclear factor-3 and liver factor B1 are differently affected by pure and partial antiestrogens. Eur J Biochem (1994) 0.93
Microarray analysis of placental tissue in intrauterine growth restriction. Clin Endocrinol (Oxf) (2009) 0.90
A highly specific and sensitive monoclonal antibody detecting histidine-tagged recombinant proteins. Protein Eng (1995) 0.89
Differential expression of drug-resistance-related genes between sensitive and resistant blasts in acute myeloid leukemia. Acta Haematol (2006) 0.89
The novel antisense Bcl-2 inhibitor SPC2996 causes rapid leukemic cell clearance and immune activation in chronic lymphocytic leukemia. Leukemia (2011) 0.89
SF/HGF is a mediator between limb patterning and muscle development. Development (1999) 0.89
Recent developments in molecular action of antihormones. J Mol Med (Berl) (1998) 0.87
The "additional subunit" CF0II of the photosynthetic ATP-synthase and the thylakoid polypeptide, binding ferredoxin NADP reductase: are they different? Z Naturforsch C (1991) 0.85
Hepatocyte growth factor/scatter factor (HGF/SF) signals via the STAT3/APRF transcription factor in human hepatoma cells and hepatocytes. FEBS Lett (1997) 0.85
E1A-mediated repression of progesterone receptor-dependent transactivation involves inhibition of the assembly of a multisubunit coactivation complex. Mol Cell Biol (2000) 0.85
Detection of pulmonary hemorrhage with technetium-labeled red cells. J Nucl Med (1981) 0.83
Biochemical and functional characterization of the murine ros protooncogene. Oncogene (1994) 0.83
Gene signatures of testicular seminoma with emphasis on expression of ets variant gene 4. Cell Mol Life Sci (2005) 0.83
[A comparative study of intravenous opioid analgesia. Sufentanil and alfentanil for extracorporeal shock-wave lithotripsy in urologic patients]. Anaesthesist (1996) 0.83
A 439 kb-sized homozygous deletion in 17p13.3 leading to biallelic loss of the ASPA as cause of Canavan disease detected by SNP-array analysis. Mol Genet Metab (2009) 0.82
Faecal short-chain fatty acids after colonic surgery. Eur J Clin Nutr (1989) 0.82
Identification of novel antigens in blood vessels in rectovaginal endometriosis. Mol Hum Reprod (2007) 0.81
TRAIL and taurolidine enhance the anticancer activity of doxorubicin, trabectedin and mafosfamide in HT1080 human fibrosarcoma cells. Anticancer Res (2012) 0.80
Liver specific transcription factors of the HNF3-, C/EBP- and LFB1-families interact with the A-activator binding site. Nucleic Acids Res (1991) 0.80
[Utilizing optical coherence tomography (OCT) for visualization of urothelial diseases of the urinary bladder]. Radiologe (2006) 0.80
Chimeric liver transcription factors LFB1 (HNF1) containing the acidic activation domain of VP16 act as positive dominant interfering mutants. J Biol Chem (1993) 0.79
[Early detection of TUR(transurethral resection) syndrome--ethanol measurement in ventilated patients]. Anasthesiol Intensivmed Notfallmed Schmerzther (1997) 0.79
Synergistic enhancement of PRB-mediated RU486 and R5020 agonist activities through cyclic adenosine 3',5'-monophosphate represents a delayed primary response. Mol Endocrinol (1998) 0.79
Activation of transcription by progesterone receptor involves derepression of activation functions by a cofactor. Mol Endocrinol (1997) 0.78
Regulation of gene expression in endothelial cells: the role of human follicular fluid. J Mol Endocrinol (2005) 0.78
Effects of TRAIL and taurolidine on apoptosis and proliferation in human rhabdomyosarcoma, leiomyosarcoma and epithelioid cell sarcoma. Int J Oncol (2013) 0.78
[Electrocorticogram and unitary activites with expanding lesions in man]. Electroencephalogr Clin Neurophysiol (1966) 0.77
[Identification of genes over-expressed in myxoid/round cell liposarcoma. DNA microarray analysis and immunohistochemical correlation]. Pathologe (2010) 0.77
[Immunonutrition after trauma]. Unfallchirurg (2011) 0.76
Use of 1 alpha-hydroxyvitamin D3 to prevent bovine parturient paresis. VI. Concentrations of vitamin D metabolites and vitamin D3 equivalence in milk. J Dairy Sci (1986) 0.76
[Ruptured saccular aneurysms of the vertebro-basilar system. Review of 19 personal and 88 published cases]. Acta Neurochir (Wien) (1969) 0.76
Recombinant activation domains of virion protein 16 and human estrogen receptor generate transcriptional interference in vitro by distinct mechanisms. Mol Endocrinol (1993) 0.76
Posterior "nutcracker" phenomenon: hemodynamic relevant aorto-retroaortal renal vein fistula leading to fatal right heart failure. Acta Radiol (2005) 0.75
Infant feeding and HIV study does not support Minerva's view. BMJ (2000) 0.75
Protecting breast feeding from breast milk substitutes. Health workers must be protected from conflicts of interest. BMJ (1998) 0.75
[Effect of caffeine on various metabolic parameters in vivo]. Z Ernahrungswiss (1984) 0.75
Familial dysautonomia (Riley-Day syndrome). Temporal bone findings and otolaryngological manifestations. Ann Otol Rhinol Laryngol Suppl (1978) 0.75
Early diet in preterm babies and later intelligence quotient. Surely study showed that breast milk is feed of choice for premature babies. BMJ (1999) 0.75
[Von Hippel-Landau's disease with multiple localizations. Cerebellar and spinal, revealed before intervention by vertebral angiography with subtraction. Heredofamilial incidence highly probable]. Neurochirurgia (Stuttg) (1966) 0.75
[Not Available]. Wurzbg Medizinhist Mitt (1998) 0.75
Task force for the future. J Med Soc N J (1965) 0.75
[Thoughts on 3 cases of operated intramedullary tumors]. Neurochirurgie (1966) 0.75
Pachydermoperiostosis--clinical spectrum. Arch Intern Med (1965) 0.75
[Aneurysms of the sylvian artery. Apropos of 75 cases]. Ann Chir (1967) 0.75
[Aneurysms of the internal carotid bilfurication]. Neurochirurgia (Stuttg) (1967) 0.75
[The arterial pedicles of supra-tentorial meningiomas. Angiographic analysis]. Neurochirurgia (Stuttg) (1967) 0.75
[On ambulant physical examinations of the brain. Value of median echoencephalography in a case of subdural empyema]. Neurochirurgie (1966) 0.75
[Motor effects of electric stimulation of the ventrolateral nucleus of the thalamus in man]. Rev Neurol (Paris) (1967) 0.75
[The assessement of 1 year of activity (October 1965-October 1966) of the intensive care section of the Clinique Neuro-Chirurgicale de la Pitié]. Neurochirurgie (1968) 0.75
[Study by microelectrodes of the relationship of electrocortical waves and unit discharges in man in certain pathological processes]. Rev Neurol (Paris) (1965) 0.75